Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| No statute on record | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGA, KYLE THOMAS | 1 | 62.4% | +43.9% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.6% | +17.0% |
| ZHU, JIANJIAN | 1 | 59.7% | +82.5% |
| NGUYEN, QUANG | 1 | 38.2% | +52.8% |
| ARIETI, RUTH SOPHIA | 1 | 45.2% | +73.6% |
| PENNINGTON, KATIE LEIGH | 1 | 27.3% | +60.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17111769 | Modified Guide RNAs for Gene Editing | PENNINGTON, KATIE LEIGH | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17897878 | LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS | NGUYEN, QUANG | 238d overdue |
| 18132278 | Polynucleotides, Compositions, and Methods for Genome Editing | POLIAKOVA-GEORGAN, EKATERINA | 147d overdue |
| 18415032 | Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four | REGA, KYLE THOMAS | 50d overdue |
| 17836265 | Modified Guide RNAs for Gene Editing | ARIETI, RUTH SOPHIA | 30d overdue |
| 17111769 | Modified Guide RNAs for Gene Editing | PENNINGTON, KATIE LEIGH | 17d overdue |
| 18050333 | Methods of in Vitro Cell Delivery | ZHU, JIANJIAN | 6d |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1636 | 1 |
| 1637 | 1 |
| 1635 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18415032 | Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four | REGA, KYLE THOMAS | 1636 | §103 | Final Rejection | 50d overdue | Pending | Jan 17, 2024 |
| 18132278 | Polynucleotides, Compositions, and Methods for Genome Editing | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Other | Final Rejection | 147d overdue | Pending | Apr 07, 2023 |
| 18050333 | Methods of in Vitro Cell Delivery | ZHU, JIANJIAN | 1631 | Other | Non-Final OA | 6d | Pending | Oct 27, 2022 |
| 17897878 | LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS | NGUYEN, QUANG | 1631 | Other | Final Rejection | 238d overdue | Pending | Aug 29, 2022 |
| 17836265 | Modified Guide RNAs for Gene Editing | ARIETI, RUTH SOPHIA | 1635 | Other | Non-Final OA | 30d overdue | Pending | Jun 09, 2022 |
| 17111769 | Modified Guide RNAs for Gene Editing | PENNINGTON, KATIE LEIGH | 1634 | §103 | Final Rejection | 17d overdue | Pending | Dec 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial